Screening begins for Covaxin volunteers to check safety of C
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Health screening of people who volunteered for the trial of Covaxin — India’s indigenous vaccine for Covid-19 — has started.

Delhi-based Dr Dangs Lab, selected as the central lab for the human clinical trials of Covaxin, an indigenous Covid-19 vaccine being developed and manufactured by Bharat Biotech in collaboration with ICMR.

It has already started receiving samples from 50 to 100 subjects per day from various trial sites for safety testing.

Covaxin is currently undergoing phase I trial, during which 375 people will be vaccinated to assess the safety of the vaccine and to calculate the dose range.

Dr Sanjay K Rai, a professor in the community medicine department at AIIMS Delhi, who is heading the trials at the institute, said health screening is being done to rule out any pre-existing illness and to study the immunity profile of volunteers.

Dr Dangs lab is processing all samples for screening and safety for the various phases of this clinical trial, whereas all the efficacy studies will be performed in NIV (Pune).

Source: https://health.economictimes.indiatimes.com/news/diagnostics/screening-begins-for-vaccine-volunteers/77118132
Dr. T●●●●z H●●●●●●i and 9 others like this5 shares
Like
Comment
Share